SRx Health Solutions Announces Receipt of Warning Letter from NYSE American

Core Viewpoint - SRx Health Solutions, Inc. received a public warning letter from NYSE Regulation Staff due to non-compliance with specific sections of the NYSE American LLC Company Guide regarding the issuance of shares [1] Group 1: Issuance of Shares - The warning letter pertains to the issuance of approximately 7.5 million shares of the Company's common stock between December 31, 2025, and January 23, 2026, following the conversion of Series A Convertible Preferred Stock [2] - The Company failed to file an application for the Exchange's listing approval for the additional shares as required under Section 301 of the Company Guide [2] - The Company also did not obtain stockholder approval for the issuance that exceeded 20% of the outstanding Common Stock, violating Section 713 of the Company Guide [2] Group 2: Stockholder Approval - Stockholder approval for the issuance of the Preferred Shares and the Common Stock upon conversion was obtained through written consent on October 8, 2025 [4] - However, the Exchange deemed this stockholder approval deficient based on its internal guidance, leading to the violations noted in the warning letter [4] Group 3: Current Status of Preferred Shares - As of the date of the report, all Preferred Shares have been either converted into Common Stock or redeemed by the Company, with no Preferred Shares remaining outstanding [5]